Raportul
Știri verificate despre finanțări, sedii centrale și leadership de la cele mai inovatoare companii din lume
197 rapoarte și mai multe
Crystalys Therapeutics Raises $130M Series B for Gout Drug Development
Crystalys Therapeutics raised an oversubscribed $130 million Series B led by Frazier Life Sciences to advance clinical development and commercialization preparation of dotinurad for gout.
Arthrosi Therapeutics raises $153M Series E at $800M valuation
Arthrosi Therapeutics raises $153M in Series E at $800M valuation. Developing next-generation gout treatment drug for chronic conditions...
Crystalys Therapeutics Raises $205M in Series A
Crystalys Therapeutics, a Biotech company based in San Diego, CA, has raised $205M in Series A at a $800M valuation led by Novo Holdings, SR One, Catalys Pacific.
Arthrosi Therapeutics Raises $153M in Series E
Arthrosi Therapeutics, a Biotech company based in San Diego, CA, has raised $153M in Series E at a $800M valuation led by New Enterprise Associates, RA Capital.
Arnatar Therapeutics raises $52M Series A
Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...
Denali Therapeutics raises $217M Series C at $5B valuation
Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...
Strand Therapeutics raises $153M Series B
Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...
Seres Therapeutics raises $113M Series E at $450M valuation
Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...
Crystalys Therapeutics raises $205M Series B at $900M valuation
Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...
Afișare 9 rapoarte • Pagina 1 • Categorie: all
Rămâneți înaintea pieței
Primiți perspective săptămânale în inbox. Fără spam, doar inteligență.